2010Chinese Journal of Hospital PharmacyRequires access

Bioequivalence of finasteride tablet in healthy volunteers by LC-MS/MS

Ying Zhang

Open publisher page 0 citations

Abstract

OBJECTIVE To study the pharmacokinetics and bioequivalence of finasteride tablets in 24 healthy male volunteers by LC-MS/MS assay.METHODS A single oral dose 1 mg of test tablets and reference tablets were given to each volunteers according to an open randomized crossover design.The concentration of finasteride in plasma was determined by LC-MS/MS.The pharmacokinetic parameters were calculated and the bioequivalence was compared.RESULTS The main pharmacokinetic parameters of the test and reference preparations were as follows:AUC0-36 were(50.317±22.478) and(48.586±22.345)μg.h.L-1;AUC0-∞ were(52.939±24.352) and(50.880±23.837)μg.h.L-1;Tmax were(1.77±0.44) and(1.79±0.41) h;Cmax were(7.758±3.314) and(7.852±3.456)μg.L-1;t1/2 were(5.10±1.33) and(4.96±1.25) h.The relative bioavailability was(106.0±20.9)%.The main pharmacokinetic parameters showed no statistically significant difference between 2 preparations.CONCLUSION The 2 preparations were bioequivalent.

About this research paper

What this paper is about

OBJECTIVE To study the pharmacokinetics and bioequivalence of finasteride tablets in 24 healthy male volunteers by LC-MS/MS assay.METHODS A single oral dose 1 mg of test tablets and reference tablets were given to each volunteers according to an open randomized crossover design.The concentration of finasteride in plasma was determined by LC-MS/MS.The pharmacokinetic parameters were calculated and the bioequivalence was compared.RESULTS The main pharmacokinetic parameters of the test and reference preparations were as follows:AUC0-36 were(50.317±22.478) and(48.586±22.345)μg.h.L-1;AUC0-∞ were(52.939±24.352) and(50.880±23.837)μg.h.L-1;Tmax were(1.77±0.44) and(1.79±0.41) h;Cmax were(7.758±3.314) and(7.852±3.456)μg.L-1;t1/2 were(5.10±1.33) and(4.96±1.25) h.The relative bioavailability was(106.0±20.9)%.The main pharmacokinetic parameters showed no statistically significant difference between 2 preparations.CONCLUSION The 2 preparations were bioequivalent.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To study the pharmacokinetics and bioequivalence of finasteride tablets in 24 healthy male volunteers by LC-MS/MS assay.METHODS A single oral dose 1 mg of test tablets and reference tablets were given to each volunteers according to an open randomized crossover design.The concentration of finasteride in plasma was determined by LC-MS/MS.The pharmacokinetic parameters were calculated and the bioequivalence was compared.RESULTS The main pharmacokinetic parameters of the test and reference preparations were as follows:AUC0-36 were(50.317±22.478) and(48.586±22.345)μg.h.L-1;AUC0-∞ were(52.939±24.352) and(50.880±23.837)μg.h.L-1;Tmax were(1.77±0.44) and(1.79±0.41) h;Cmax were(7.758±3.314) and(7.852±3.456)μg.L-1;t1/2 were(5.10±1.33) and(4.96±1.25) h.The relative bioavailability was(106.0±20.9)%.The main pharmacokinetic parameters showed no statistically significant difference between 2 preparations.CONCLUSION The 2 preparations were bioequivalent.

Key concepts: Bioequivalence, Pharmacokinetics, Cmax, Bioavailability, Finasteride, Crossover study, Pharmacology, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Bioequivalence of finasteride tablet in healthy volunteers by LC-MS/MS — Research Paper | ScholarLens